DaVita Inc.

156 articles with DaVita Inc.

• DaVita Reports on 2018 Corporate Social Responsibility Initiatives

  5/15/2019

  Company highlights achievements in patient care, community growth and sustainability

• DaVita Inc. 1st Quarter 2019 Results

  5/7/2019

  DaVita Inc. announced results for the quarter ended March 31, 2019.

• DaVita Announces CEO Succession

  4/29/2019

  Javier J. Rodriguez named CEO effective June 1, 2019; Kent J. Thiry to serve as Executive Chairman of the board of directors

• DaVita Inc. Schedules 1st Quarter 2019 Investor Conference Call

  4/26/2019

  DaVita Inc. announced that it will hold its quarterly conference call to discuss first quarter results on Tuesday, May 7, 2019, at 5:00 p.m. Eastern Time.

• DaVita to Use 100 Percent Renewable Energy

  4/25/2019

  By 2022, DaVita Inc. (NYSE: DVA) expects to use 100 percent renewable energy.

• Helping Patients Along Their Kidney Transplant Journey

  4/24/2019

  DaVita launches education and support program to help patients pursue a kidney transplant

• Empowering the Kidney Care Community: Kidney Disease Treatment Options to Fit Many Lifestyles

  3/1/2019

  DaVita Kidney Care raises awareness about modality options with educational resources in support of National Kidney Month

• DaVita Celebrates 12 Consecutive Years Among FORTUNE® Magazine's World's Most Admired Companies®

  2/21/2019

  Company values innovation and continuous improvement of patient care

• DaVita Inc. 4th Quarter 2018 Results

  2/13/2019

  DaVita Inc. announced results for the quarter and year ended December 31, 2018.

• DaVita Inc. Schedules 4th Quarter 2018 Investor Conference Call

  1/30/2019

  DaVita Inc. announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 14, 2019, at 9:00 a.m. Eastern Time.

• New Technology Helps Nephrologists Better Manage Patients with Chronic Kidney Disease

  1/17/2019

  DaVita Physician Solutions rolls out CKD EHR by Epic nationwide

• 

  JP Morgan Healthcare Conference Update: FDA, bluebird, Moderna and the Price of Coffee

  1/9/2019

  Tuesday, January 8, was another busy day in San Francisco for the JP Morgan Healthcare Conference. One interesting sideline was the idea that the current government shutdown could complicate some deals.

• DaVita Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference

  1/7/2019

  DaVita Inc. announced that it will participate in the 37th Annual J.P. Morgan Healthcare Conference being held January 7-10, 2019, at the Westin St. Francis Hotel in San Francisco, CA. Kent Thiry, Chairman and CEO, will be presenting on Monday, January 7, at 5:00 p.m. Pacific Time.

• DaVita Celebrates 2018 Achievements

  12/26/2018

  Teammates Deliver Clinical Excellence, Improved Patient Care, Innovation, Robust Partnerships, Community Leadership

• DaVita Teammates Directed Donations of More Than $2.1 Million and Volunteered 25,360 Hours in 2018

  12/18/2018

  DaVita teammates give back to their local communities

• New Holiday Cookbook Addresses Diet and Nutrition Needs of Those with Kidney Disease

  11/19/2018

  DaVita Kidney Care releases 'Holiday Gatherings' Cookbook

• DaVita Responds to Proposition 8 in California

  11/7/2018

  DaVita Kidney Care is a leading provider of kidney care services in the United States

• DaVita Inc. 3rd Quarter 2018 Results

  11/7/2018

  DaVita Inc. today announced results for the quarter ended September 30, 2018.

• Approximately 1 in 3 Adults with Diabetes May Develop Chronic Kidney Disease

  11/1/2018

  DaVita raises awareness about link between diabetes and CKD during National Diabetes Awareness Month

• DaVita Named to Dow Jones Sustainability World Index

  10/24/2018

  DaVita Inc. announced today that the company has been recognized for the second time by the Dow Jones Sustainability Indices (DJSI) and is one of only seven U.S.- based companies in the Health Care Providers and Services category on this year's DJSI World Index.